1252 related articles for article (PubMed ID: 25870282)
41. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
42. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
[TBL] [Abstract][Full Text] [Related]
43. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
44. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
[TBL] [Abstract][Full Text] [Related]
45. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
Pohodich AE; Zoghbi HY
Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
[TBL] [Abstract][Full Text] [Related]
46. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.
Chapleau CA; Calfa GD; Lane MC; Albertson AJ; Larimore JL; Kudo S; Armstrong DL; Percy AK; Pozzo-Miller L
Neurobiol Dis; 2009 Aug; 35(2):219-33. PubMed ID: 19442733
[TBL] [Abstract][Full Text] [Related]
47. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.
Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
49. Evolving role of MeCP2 in Rett syndrome and autism.
LaSalle JM; Yasui DH
Epigenomics; 2009 Oct; 1(1):119-30. PubMed ID: 20473347
[TBL] [Abstract][Full Text] [Related]
50. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
51. The molecular pathology of Rett syndrome: synopsis and update.
Akbarian S; Jiang Y; Laforet G
Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
[TBL] [Abstract][Full Text] [Related]
52. Reading the unique DNA methylation landscape of the brain: Non-CpG methylation, hydroxymethylation, and MeCP2.
Kinde B; Gabel HW; Gilbert CS; Griffith EC; Greenberg ME
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6800-6. PubMed ID: 25739960
[TBL] [Abstract][Full Text] [Related]
53. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
Young JI; Hong EP; Castle JC; Crespo-Barreto J; Bowman AB; Rose MF; Kang D; Richman R; Johnson JM; Berget S; Zoghbi HY
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17551-8. PubMed ID: 16251272
[TBL] [Abstract][Full Text] [Related]
54. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
[TBL] [Abstract][Full Text] [Related]
55. The methyl-CpG-binding protein MeCP2 and neurological disease.
Bird A
Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
[TBL] [Abstract][Full Text] [Related]
56. MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes.
Boxer LD; Renthal W; Greben AW; Whitwam T; Silberfeld A; Stroud H; Li E; Yang MG; Kinde B; Griffith EC; Bonev B; Greenberg ME
Mol Cell; 2020 Jan; 77(2):294-309.e9. PubMed ID: 31784358
[TBL] [Abstract][Full Text] [Related]
57. Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.
Bach S; Ryan NM; Guasoni P; Corvin AP; El-Nemr RA; Khan D; Sanfeliu A; Tropea D
Sci Rep; 2020 Dec; 10(1):22255. PubMed ID: 33335218
[TBL] [Abstract][Full Text] [Related]
58. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
Nag N; Mellott TJ; Berger-Sweeney JE
Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
[TBL] [Abstract][Full Text] [Related]
59. Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.
Rousseaud A; Delépine C; Nectoux J; Billuart P; Bienvenu T
J Mol Neurosci; 2015 Aug; 56(4):758-767. PubMed ID: 25634725
[TBL] [Abstract][Full Text] [Related]
60. The neurobiology of Rett syndrome.
Akbarian S
Neuroscientist; 2003 Feb; 9(1):57-63. PubMed ID: 12580340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
